Harmony Biosciences Holdings, Inc. (HRMY) Tops Q4 Earnings and Revenue Estimates
Portfolio Pulse from
Harmony Biosciences Holdings, Inc. (HRMY) reported Q4 earnings of $0.85 per share, surpassing the Zacks Consensus Estimate of $0.74. This marks a significant increase from $0.45 per share a year ago.
February 25, 2025 | 3:00 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Harmony Biosciences reported Q4 earnings of $0.85 per share, exceeding expectations and showing strong growth from the previous year.
The company's earnings per share significantly exceeded analyst expectations and showed substantial growth compared to the previous year, which is likely to positively impact the stock price in the short term.
CONFIDENCE 95
IMPORTANCE 90
RELEVANCE 100